Condition
Pleural Infections and Inflammations
Total Trials
3
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 4 (1)
Trial Status
Completed1
Not Yet Recruiting1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07095361Phase 4Recruiting
Once Daily Intrapleural Enzyme Therapy in Complicated Parapneumonic Effusion or Empyema
NCT07550530Not ApplicableNot Yet Recruiting
Role of Medical Thoracoscopy in Pleural Infection (PROMPT Trial)
NCT06513689Completed
The Oxford Pleural Infection Endotyping Study
Showing all 3 trials